If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 61 Similar Profiles
Natural Killer Cells Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
Fetal Blood Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences
KIR Receptors Medicine & Life Sciences
Transplants Medicine & Life Sciences
Transplantation Medicine & Life Sciences
Interleukin-15 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1996 2024

Epithelial Cell Adhesion Molecule
myeloid leukemia
natural killer cells
Natural Killer Cell Receptors
Transplantation
Neoplasms
Therapeutics

Research Output 1991 2019

Assessing canonical and adaptive natural killer cell function in suppression assays in vitro

Sarhan, D. & Miller, J. S., Jan 1 2019, Methods in Molecular Biology. Humana Press Inc., p. 153-166 14 p. (Methods in Molecular Biology; vol. 1913).

Research output: Chapter in Book/Report/Conference proceedingChapter

Natural Killer Cells
Regulatory T-Lymphocytes
Cytomegalovirus
Neoplasms
Coculture Techniques
2 Citations (Scopus)
Natural Killer Cells
Ovarian Neoplasms
Cytokines
Immunosuppressive Agents
Ascites

Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis

Bachanova, V., Weisdorf, D. J., Wang, T., Marsh, S. G. E., Cereb, N., Haagenson, M. D., Spellman, S. R., Lee, S. J., Guethlein, L. A., Parham, P., Miller, J. S. & Cooley, S. A., May 1 2019, In : Biology of Blood and Marrow Transplantation. 25, 5, p. 949-954 6 p.

Research output: Contribution to journalArticle

KIR Receptors
Unrelated Donors
B-Cell Chronic Lymphocytic Leukemia
Leukemia
Bone Marrow

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab

Erbe, A. K., Wang, W., Carmichael, L., Hoefges, A., Grzywacz, B. J., Reville, P. K., Ranheim, E. A., Hank, J. A., Kim, K. M., Seo, S., Mendonca, E. A., Song, Y., Kenkre, V. P., Hong, F., Gascoyne, R. D., Paietta, E., Horning, S. J., Miller, J. S., Kahl, B. & Sondel, P. M., Mar 12 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 70.

Research output: Contribution to journalArticle

Open Access
KIR Receptors
Follicular Lymphoma
Ligands
Genotype
Natural Killer Cells
3 Citations (Scopus)

KIR Donor Selection: Feasibility in Identifying better Donors

the participating center writing committee, Jan 1 2019, In : Biology of Blood and Marrow Transplantation. 25, 1, p. e28-e32

Research output: Contribution to journalArticle

Donor Selection
Immunoglobulins
Tissue Donors
Transplants
Acute Myeloid Leukemia